Pharming Group Earnings Estimate

By analyzing Pharming Group's earnings estimates, investors can diagnose different trends across Pharming Group's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for Pharming Group NV is based on EPS before non-recurring items and includes expenses related to employee stock options. Pharming Group is projected to generate -0.003125 in earnings per share on the 31st of December 2024. Pharming Group earnings estimates module stress-tests analyst consensus about projected Pharming Group NV EPS (Earning Per Share) to derive its highest and lowest estimates based on its historical volatility. Many public companies, such as Pharming Group, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Pharming Group's earnings estimates, investors can diagnose different trends across Pharming Group's analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Pharming Group's Gross Profit is relatively stable compared to the past year. As of 11/26/2024, Gross Profit Margin is likely to grow to 0.94, while Pretax Profit Margin is likely to drop (0.05). Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Pharming Group NV. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.